Fluconazole 첨가 사브로덱스트로오스 한천 배지를 사용한 Candida 종의 Fluconazole 내성 검색 = Screening of Fluconazole-Resistant Candida Species with Fluconazole-Containing Sabouraud Dextrose Agar Plates

다국어 초록 (Multilingual Abstract)

Background: Antifungal susceptibility testing methods are relatively expensive and laborious and are not easily applicable for screening purposes in routine laboratories.
Objective: We have developed a susceptibility screening method by adding fluconazole to Sabouraud dextrose agar (SDA) plate. In this study, SDA plates screening was compared with the Clinical and Laboratory Standards Institutes (CLSI) broth microdilution method for determining fluconazole
susceptibility of Candida spp.
Methods: A total 186 isolates of Candida spp. (134 C. albicans, 24 C. tropicalis, 15 C. glabrata, 13 C. parapsilosis) were tested with the CLSI document M27-A2 method and fluconazole-containing SDA plate (0, 8, 16 μg/mL of fluconazole). By this method, colony count and diameter were read after 24 hr of incubation.
Results: Fluconazole-susceptible Candida spp. are significantly smaller (≤50%) on SDA with fluconazole than on fluconazole-free SDA. On SDA with 8 and 16 μg of fluconazole per mL, 80.7% (150/186) and 87.1% (162/186) of isolates were correctly predicted, respectively.
Conclusions: These data suggest that the fluconazole-containing SDA plates can be used as a routine screening procedure for susceptibility of Candida spp. in clinical laboratories.

다국어 초록 (Multilingual Abstract)

Background: Antifungal susceptibility testing methods are relatively expensive and laborious and are not easily applicable for screening purposes in routine laboratories.
Objective: We have developed a susceptibility screening method by adding fluconazole to Sabouraud dextrose agar (SDA) plate. In this study, SDA plates screening was compared with the Clinical and Laboratory Standards Institutes (CLSI) broth microdilution method for determining fluconazole
susceptibility of Candida spp.
Methods: A total 186 isolates of Candida spp. (134 C. albicans, 24 C. tropicalis, 15 C. glabrata, 13 C. parapsilosis) were tested with the CLSI document M27-A2 method and fluconazole-containing SDA plate (0, 8, 16 μg/mL of fluconazole). By this method, colony count and diameter were read after 24 hr of incubation.
Results: Fluconazole-susceptible Candida spp. are significantly smaller (≤50%) on SDA with fluconazole than on fluconazole-free SDA. On SDA with 8 and 16 μg of fluconazole per mL, 80.7% (150/186) and 87.1% (162/186) of isolates were correctly predicted, respectively.
Conclusions: These data suggest that the fluconazole-containing SDA plates can be used as a routine screening procedure for susceptibility of Candida spp. in clinical laboratories.

참고문헌 (Reference)

1 Hospenthal DR, "The role of antifungal susceptibility testing in the therapy of candidiasis" 48 : 153-160, 2004

2 Vandenbossche I, "Susceptibility testing of fluconazole by the NCCLS broth macrodilution method, E-test, and disk diffusion for application in the routine laboratory" 40 : 918-921, 2002

3 Patterson TF, "Simple method for detecting fluconazole-resistant yeasts with chromogenic agar" 34 : 1794-1797, 1996

4 Clinical and Laboratory Standards Institutes, "Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2, 2nd ed" National Committee for Clinical Laboratory Standards 2002

5 Pfaller MA, "Multicenter comparision of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconasole against Candida spp" 45 : 796-802, 2007

6 Asmundsdottir LR, "Increasing incidence of candidemia: Results from a 20-year nationwide study in Iceland" 40 : 3489-3492, 2002

7 Mcneil MM., "Fungal infections in: Hospital epidemiology and infection control. 3rd ed" Lippincott Williams and Wilkins 685-707, 2004

8 Joung YH, "Fluconazole susceptibility testing of Candida species by flow cytometry" 54 : 504-508, 2007

9 Lee MK, "Evaluation of disk diffusion test with glucose- and methylene blue-enriched Mueller- Hinton agar for in vitro susceptibility testing of fluconazole against Candida isolates" 25 : 247-251, 2005

10 Nelson SM, "Detection of fluconazoleresistant isolates of Candida glabrata by using an agar screen assay" 41 : 2141-2143, 2003

11 Patterson TF, "Comparative evaluation of macrodilution and chromogenic agar screening for determining fluconazole susceptibility of Candida albicans" 34 : 3237-3239, 1996

12 김태형, "Candida 종에 의한 병원-획득성 요로감염에서 위험인자 분석" 대한의진균학회1 12 (12): 156-162, 2007

13 Rex JH, "Antifungal susceptibility testing: Practical aspects and current challenges" 14 : 643-658, 2001